TD Cowen analyst Robert Moskow has maintained their bullish stance on CL stock, giving a Buy rating today.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Robert Moskow has given his Buy rating due to a combination of factors that showcase Colgate-Palmolive’s potential despite recent challenges. The company’s strong market share gains have reinforced confidence in its business momentum, even though the guidance for 2025 sales and EPS fell slightly below consensus expectations. Colgate-Palmolive’s strategic increase in US production by 40% over the past five years is seen as a mitigating factor against potential tariff risks, which could affect certain product categories.
While North American organic sales declined slightly, the management’s positive outlook on volume trends and emerging improvements in toothpaste, liquid hand soap, and dish soap provide optimism for future growth. Although Hill’s organic sales experienced a sequential slowdown, the company’s previous capacity expansions in wet dog food are expected to support continued performance. These strategic efforts and market dynamics contribute to Moskow’s confident Buy rating for Colgate-Palmolive.
In another report released today, Morgan Stanley also maintained a Buy rating on the stock with a $104.00 price target.
Based on the recent corporate insider activity of 86 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CL in relation to earlier this year.